Malawi-Liverpool-Wellcome Trust (MLW) Clinical Research Programme, Blantyre
Blantyre 3, Blantyre, Malawi
Purpose
To define the immunogenicity of Mtb antigens across the respiratory mucosa and peripheral blood in adults living in a TB-endemic setting to generate an evidence-based framework for next-generation TB vaccine antigen prioritization.
Division
Global Health
Date
October 2026
Region Served
GLOBAL
Committed amount
$2,975,565
Grant topic
Discovery and Translational Sciences, Tuberculosis
Duration (months)
50
Grantee location
Blantyre 3, Blantyre, Malawi
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.